Christopher J McDougle, M.D.
This page shows the publications co-authored by Christopher McDougle and Caitlin Ravichandran.
A randomized double-blind, placebo-controlled pilot trial of mirtazapine for anxiety in children and adolescents with autism spectrum disorder. Neuropsychopharmacology. 2022 Mar 03.
Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Adults with Down Syndrome: A Preliminary Retrospective Chart Review Study. Brain Sci. 2021 Sep 15; 11(9).
Parent Description of Anxiety in Angelman Syndrome. J Autism Dev Disord. 2021 Aug 20.
Repetitive Thoughts and Repetitive Behaviors in Williams Syndrome. J Autism Dev Disord. 2022 Feb; 52(2):852-862.
Agitation in Patients With Autism Spectrum Disorder Admitted to Inpatient Pediatric Medical Units. Pediatrics. 2020 04; 145(Suppl 1):S108-S116.
Accuracy of self-reported history of autoimmune disease: A pilot study. PLoS One. 2019; 14(5):e0216526.
Beyond the brain: A multi-system inflammatory subtype of autism spectrum disorder. Psychopharmacology (Berl). 2019 Oct; 236(10):3045-3061.
Characterization of sleep habits and medication outcomes for sleep disturbance in children and adults with Angelman syndrome. Am J Med Genet A. 2020 08; 182(8):1913-1922.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.